Description: The presentation discusses the history of the Medicare+Choice [M+C] program and the challenges faced by plans offering the program, as well as the challenges faced by those interested in entering the program. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 60

Description: Panel covers a variety of current issues in the Medicare supplement marketplace, including the impact of the Balanced Budget Act of 1997. Issues affecting both managed care and traditional Medicare supplement are discussed. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: Conditions and required solvency standards of federal waiver to PSOs to provide Medicare+Choice products. Effect on providers, beneficiaries and employers. Issue No. 36

Description: This article provides an introduction to the Medicare Prescription Drug, Improvement and Modernization Act of 2003 and looks at how the Medicare prescription drug plan will affect the commercial market as well as, what PDPs will offer for benefits and if any will offer supplemental benefits. From Health Section News, March 2005, Issue No. 49.

Description: Panelists discuss different aspects of self-selection among Medicare options. From the Record of the Society of Actuaries, Vol. 24, No. 2.

Description: The moderator will review senior health products: Medicare supplement, Medicare risk, hospital indemnity policy HIP, cancer, accidental death AD, and employer continuance. Discussion will include product design, pricing, administration, regulation, and marketing. From the Record of the Society of Actuaries, Vol. 21, No. 1.

Description: Panelists explore issues facing carriers of Medicare Supplement products, including high trend, fixed designs, limited underwriting ability, legislation, National Association of Insurance Commissioners [NAIC] pursuits, and the American Academy of Actuaries [AAA] task force. From the Record of the Society of Actuaries, Volume 27, No. 1, Session 66

Description: This article compares the Prescription Drug Plan (PDP) market to the commercial individual market exchanges included in the Affordable Care Act. PDP carrier actions to date could help predict certain aspects of the exchange market.

Description: In session 26PD of the 2004 Valuation Actuary Symposium, discussed is how the new Medicare prescription drug legislation creates a number of issues for employers and managed-care plans. Employers must determine the impact of the legislation on their retiree prescription drug costs, evaluate options for plan design and make decisions about how to reflect the effect of the legislation in their FAS 106 valuations. Managed-care plans need to review the effect of the legislation on plan design, statutory filings and financial reporting for their Medicare products.

Description: The American Academy of Actuaries is engaged in several projects that proactively examine the future status of the Medicare Program. This session presents the findings that have resulted from these efforts. From the Record of the Society of Actuaries, Vol. 24, No. 2.